Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market projected to reach US$ 676.6 million by 2030 | CAGR of 10.7%

Market Overview The global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market was valued at US$ 342.4 million in 2023 and is projected to reach US$ 676.6 million by 2030, at a CAGR of 10.7% during the forecast period. The Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market is witnessing steady growth attributed to the rising awareness regarding porcine health management and the increasing demand for efficient vaccines. PRRS, a viral disease prevalent in swine, poses significant economic burdens on the swine industry worldwide. To combat this challenge, the market for PRRS vaccines has gained traction, driven by advancements in vaccine technology…